Atypical antipsychotics in the treatment of schizophrenia. Cost is a crucial issue
Duggins, R.; Rhinds, D.; Hall, W.
Bmj 322(7291): 926; Author Reply 927-8
2001
ISSN/ISBN: 0959-8138 PMID: 11302921 Document Number: 533236
Document emailed within 1 workday
Related Documents
Taylor, D. 2001: Atypical antipsychotics in the treatment of schizophrenia. Pragmatic considerations are important when considering which drug to prescribe Bmj 322(7291): 925; Author Reply 927-8Lee, S. 2001: Atypical antipsychotics in the treatment of schizophrenia. "Informed relationship between doctor and patient" does not exist in many parts of the world Bmj 322(7291): 925
Gasquet, I.; Bouhassira, M.; Launois, R. 2005: Cost analysis of the strategies in the treatment of schizophrenics: the place of sustained release injectable atypical antipsychotics L'Encephale 31(4 Part 1): 517-518
Szulc, A.; Galińiska, B.; Tarasów, E.; Dzienis, W.; Kubas, B.; Konarzewska, B.; Waszkiewicz, N.; Popławska, R. 2010: The influence of atypical antipsychotics on brain functioning in schizophrenia. a proton magnetic resonance study Psychiatria Polska 44(3): 415-426
Puri, B.K.; Davey, N.J.; Zaman, R. 2003: Excitability of the motor cortex in schizophrenia following typical and atypical antipsychotics: two serial case reports International Journal of Clinical Practice 57(9): 831-833
Mahendran, R.; Liew, E.; Subramaniam, M. 2007: De novo emergence of obsessive-compulsive symptoms with atypical antipsychotics in asian patients with schizophrenia or schizoaffective disorder: a retrospective, cross-sectional study Journal of Clinical Psychiatry 68(4): 542-545
Findling, R.L. 2004: Atypical antipsychotics in the treatment of children and adolescents Journal of Clinical Psychiatry 65(Suppl): 3-4
Mastroeni, A.; Bellotti, C.; Galletti, F.; Lai, E.; Pellegrini, E.; Falloon, I. 2003: Treatment quality as a crucial issue in the process of closing Como Mental Hospital Seishin Shinkeigaku Zasshi 105(9): 1168-1174
Rayikanti, R.; Lentowicz, I.; Birur, B.; Li, L. 2017: Combined Antipsychotics and Electroconvulsive Therapy in an Acutely Psychotic Patient with Treatment-resistant Schizophrenia Psychopharmacology Bulletin 47(2): 57-62
Hrdlicka, M.; Zedkova, I.; Blatny, M.; Urbanek, T. 2009: Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study Neuro Endocrinology Letters 30(2): 256-261
Van Doorn, H.; Oberklaid, F. 1994: Children's health: a crucial issue Australian Family Physician 23(10): 1845
Masi, G. 1997: Atypical neuroleptics in the treatment of early onset schizophrenia Panminerva Medica 39(3): 215-221
Armer, R.; Miller, D.J. 2000: Recent advances in atypical antipsychotics Current Opinion in Investigational Drugs 1(4): 481-493
Jones, B.; Basson, B.R.; Walker, D.J.; Crawford, A.M.; Kinon, B.J. 2001: Weight change and atypical antipsychotic treatment in patients with schizophrenia Journal of Clinical Psychiatry 62(Suppl): 41-44
Rollini, M.; Schulz, P. 2008: Atypical antipsychotics for elderly patients: to prescribe or to ban? Revue Medicale Suisse 4(153): 979
Frecska, E. 2005: From cradle to grave? Expectations from atypical antipsychotics Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 7(1): 34-38
Farver, D. 2007: The outpatient use of atypical antipsychotics with Alzheimer's disease South Dakota Medicine: the Journal of the South Dakota State Medical Association 60(3): 113; 115
Glazer, W.M. 2000: Expected incidence of tardive dyskinesia associated with atypical antipsychotics Journal of Clinical Psychiatry 61(Suppl): 21-26
Haberfellner, E.M.; Honsig, T. 2003: Nonalcoholic steatohepatitis: a possible side effect of atypical antipsychotics Journal of Clinical Psychiatry 64(7): 851
Tsygankov, B.D.; Agasarian, E.G. 2010: The comparative efficacy of therapy with typical and atypical antipsychotics Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(9): 83-86